This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2022
ASCO GU 2022
Prostate Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
ASCO GU 2022 Prostate Cancer
Viewing 1-20 of 172 articles
ASCO GU 2022: A Path Forward: Addressing Disparities in Genitourinary Cancers
ASCO GU 2022: Treatment Outcomes for mCRPC Following Progression on Upfront ADT with Androgen Receptor Pathway Inhibitors for mCSPC
ASCO GU 2022: The TRAP Trial: Targeting Resistant Prostate Cancer, with or without DNA Repair Defects, Using the Combination of Ceralasertib and Olaparib
ASCO GU 2022: Real-World Health-Related Quality of Life and Caregiver Needs in Patients with mHSPC and mCRPC
ASCO GU 2022: Real-World Analyses of Major Adverse Cardiovascular Event Risk by Drug Class After Initiation of ADT
ASCO GU 2022: Real World Treatment Patterns Among Patients with mCRPC in the United States
ASCO GU 2022: Radiation Therapy in Localized Disease: Changing Horizons
ASCO GU 2022: Quantitative Assessment of PSMA Imaging Before and After 177Lu-PSMA-617 Treatment in a Phase I/II Trial
ASCO GU 2022: PROTEUS: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Apalutamide plus ADT Versus Placebo plus ADT Prior to Radical Prostatectomy in Patients with Localized or Locally Advanced High-Risk Prostate Cancer
ASCO GU 2022: Prevalence and Natural History of Non-Metastatic Castrate Resistant Prostate Cancer: A Population-Based Analysis
ASCO GU 2022: Preliminary Results of the "DUO" Observational Study: Quality of Life Assessment and Cross-Sectional Follow-up of Prostate Cancer Patients Treated with Degarelix
ASCO GU 2022: Preferences and Perceptions of Patients with mCRPC for Treatments and Biomarker Testing: An International Qualitative Study
ASCO GU 2022: Phase 1b Study of Tarlatamab, a Half-Life Extended Bispecific T-Cell Engager (HLE BiTE Immune Therapy) Targeting DLL3, in De Novo or Treatment Emergent Neuroendocrine Prostate Cancer
ASCO GU 2022: Phase 1 study of PSCA-targeted CAR T cell therapy for mCRPC
ASCO GU 2022: Novel Framework for Treatment Response Evaluation Using PSMA-PET/CT in Patients with mCRPC (RECIP): An International Multicenter Study
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
ASCO GU 2022: Disparities in Prostate Cancer: An Ethnicity Comparative Focus Among Hispanic Americans Versus Non-Hispanic Whites
ASCO GU 2022: The Effects of a Preference-Based Exercise Trial on Outcomes in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancer Compared to an Exercise Randomized Controlled Trial of the Same Interventions
ASCO GU 2022: Outcomes of an Advanced Practice Nurse (APN)-Led Cancer Genetics Service
ASCO GU 2022: Evaluation of Compliance of Next-Generation Sequencing (NGS) Testing in Stage IV Genitourinary (GU) Cancer Patients and the Effect of an EHR Prompt (EP) on Increasing Frequency
1
2
3
4
5
6
7
8
9
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free